A Longevity Fund Focused on Young Companies
Learning from “Elite” Responders to Develop Better Immunotherapies
Bringing Precision Medicine to the Treatment of Obesity
Expanding the Promise of RNA Therapies
Triggering a Systemic Immune Response Against Cancer
Targeting RNA Dysregulation in Cancer
Building a Pipeline of Next-Generation Kinase Inhibitors
Rethinking How Cell and Gene Therapies Are Made to Improve Accessibility
Developing Next-Generation Radiopharmaceuticals
Why Great Science and Data Aren’t Enough
Targeting Sugars that Let Cancers Evade the Immune System
Engineering Stem Cells to Withstand Targeted Therapies
Targeting a Convergence of Signaling Pathways that Drive the Growth and Spread of Cancer
Moving from Preservation to Restoration with Off-the-Shelf Cell Therapies
Using Gene Therapies to Treat Chronic, Inflammatory Conditions
Unlocking the Full Potential of Antibody Therapies
Combatting Superbugs and Emerging Viruses
How a Plant-Derived Gel Halts Bleeding in Seconds
Exploiting a Vulnerability in Cancers
Democratizing AI
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Short Wave
Stuff To Blow Your Mind
Unexplainable
COMPLEXITY